Pharmabiz
 

Roche extends cash tender offer to acquire Illumina

Basel, SwitzerlandMonday, February 27, 2012, 18:00 Hrs  [IST]

Roche has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc., at a price of $44.50 per share, to 6:00 p.m., New York City time, on March 23, 2012. The tender offer was previously scheduled to expire at 12:00 midnight, New York City time, at the end of the day on February 24, 2012.

All other terms and conditions of the offer remain unchanged. As of 12:00 midnight, New York City time, at the end of the day on February 24, 2012, approximately 102,165 shares, including 44,152 shares guaranteed to be delivered within the next three NASDAQ trading days, had been tendered and not withdrawn pursuant to the offer.

Greenhill & Co., LLC and Citigroup Global Markets, Inc. are acting as financial advisors to Roche and Davis Polk & Wardwell LLP is acting as legal counsel. more

 
[Close]